ClinicalTrials.Veeva

Menu

Value of Fecal Calprotectin

Indiana University logo

Indiana University

Status

Completed

Conditions

Calprotectin
Inflammatory Bowel Disease

Study type

Observational

Funder types

Other

Identifiers

NCT00577928
060362
IRB# 0603-62

Details and patient eligibility

About

For the main goal - the accuracy of calprotectin for the diagnosis of IBD - calprotectin levels will be compared between patients with and without a diagnosis of IBD and the sensitivity, specificity and accuracy will be determined. For the secondary aim - the correlation between calprotectin levels and disease activity - in patients with IBD selected from this cohort, we will determine the association between calprotectin levels and clinical IBD score, serological markers (WBC, Hgb, Platelets, ESR, CRP, Albumin), endoscopic (disease score, pathological activity) and radiological features (bowel wall thickening, enhancement, edema, mesenteric inflammation).

Enrollment

171 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Calprotectin assay at IU in last 12 months

Trial design

171 participants in 2 patient groups

1
2

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems